Diabetes and bone. Focus on DPP-4 inhibitors

Pathology of bone homeostasis in diabetes mellitus (DM) is a significant problem that must be considered when selecting anti-diabetic therapy. Many anti-diabetic drugs have a specific effect on bone homeostasis which should be taken into account when selecting treatment for type 2 diabetes, especial...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: A. Y. Babenko, V. S. Nikitin, T. L. Karonova
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: Remedium Group LLC 2015-12-01
Seri Bilgileri:Медицинский совет
Konular:
сахарный диабет, остеопороз, костный метаболизм, противодиабетические препараты, метформин
препараты сульфонилмочевины
ингибиторы натрий-глюкозного котранспортера 2-го типа
тиазолидиндионы
ингибиторы дипепидил-пептидазы-4б
агонисты рецепторов глюкагоноподобного пептида-1
diabetic nephropathy
osteoporosis
bone metabolism
antidiabetic drugs
metformin
sulfonylureas
thiazolidinediones
dipeptidyl peptidase-4 inhibitors
glucagon-like peptide-1 receptor agonists
sodium-glucose cotransporter 2 inhibitors
Online Erişim:https://www.med-sovet.pro/jour/article/view/435
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller